Increased expression of PPARγ in high fat diet-induced liver steatosis in mice
作者： Mitsutaka Inoue , Takaaki Ohtake , Wataru Motomura , Nobuhiko Takahashi , Yayoi Hosoki
DOI: 10.1016/J.BBRC.2005.08.070
关键词: CD36 、 Cholesterol 、 Endocrinology 、 CREB 、 Lipid metabolism 、 Internal medicine 、 Gene expression profiling 、 Fatty liver 、 Receptor 、 Peroxisome proliferator-activated receptor 、 Biology
摘要: … (A) and Oil-Red O (B) staining of liver tissue in mice fed with control diet and high fat diet. Mice of high fat diet … Control mice were fed with normal diet that contained 13.2% of calories. …
elsevier.com
sci-hub.se 参考文章(34)
Roshanak Rahimian, Esther Masih‐Khan, Maggie Lo, Cornelis van Breemen, Bruce M. McManus, Gregory P. Dubé, Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Molecular and Cellular Biochemistry. ,vol. 224, pp. 29- 37 ,(2001) , 10.1023/A:1011927113563
Mercedes Ricote, Andrew C. Li, Timothy M. Willson, Carolyn J. Kelly, Christopher K. Glass, The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation Nature. ,vol. 391, pp. 79- 82 ,(1998) , 10.1038/34178
Stephan Herzig, Fanxin Long, Ulupi S Jhala, Susan Hedrick, Rebecca Quinn, Anton Bauer, Dorothea Rudolph, Gunther Schutz, Cliff Yoon, Pere Puigserver, Bruce Spiegelman, Marc Montminy, None, CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 Nature. ,vol. 413, pp. 179- 183 ,(2001) , 10.1038/35093131
Peter Tontonoz, Robert Walczak, PPARadigms and PPARadoxes: expanding roles for PPARγ in the control of lipid metabolism Journal of Lipid Research. ,vol. 43, pp. 177- 186 ,(2002) , 10.1016/S0022-2275(20)30159-0
J BROCKMAN, R GUPTA, R DUBOIS, Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells Gastroenterology. ,vol. 115, pp. 1049- 1055 ,(1998) , 10.1016/S0016-5085(98)70072-1
C F Burant, S Sreenan, K Hirano, T A Tai, J Lohmiller, J Lukens, N O Davidson, S Ross, R A Graves, Troglitazone Action Is Independent of Adipose Tissue Journal of Clinical Investigation. ,vol. 100, pp. 2900- 2908 ,(1997) , 10.1172/JCI119839
Wataru Motomura, Nobuhiko Takahashi, Miho Nagamine, Mitsuko Sawamukai, Satoshi Tanno, Yutaka Kohgo, Toshikatsu Okumura, Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells. International Journal of Cancer. ,vol. 108, pp. 41- 46 ,(2004) , 10.1002/IJC.11561
P. Tontonoz, S. Singer, B. M. Forman, P. Sarraf, J. A. Fletcher, C. D. M. Fletcher, R. P. Brun, E. Mueller, S. Altiok, H. Oppenheim, R. M. Evans, B. M. Spiegelman, Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 237- 241 ,(1997) , 10.1073/PNAS.94.1.237
Martin Haluzik, Marc L. Reitman, Oksana Gavrilova, Sun-Hee Yim, Jerrold M. Ward, Bryan Brewer, Frank J. Gonzalez, Kimihiko Matsusue, Gilles Lambert, Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes Journal of Clinical Investigation. ,vol. 111, pp. 737- 747 ,(2003) , 10.1172/JCI17223
Marc Bedoucha, Elke Atzpodien, Urs A. Boelsterli, Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones Journal of Hepatology. ,vol. 35, pp. 17- 23 ,(2001) , 10.1016/S0168-8278(01)00066-6